Related Experiment Video
Updated: Mar 15, 2026

Quantifying the Binding Interactions Between CuII and Peptide Residues in the Presence and Absence of Chromophores
Published on: April 5, 2022
Copper(II) ions affect the gating dynamics of the 20S proteasome: a molecular and in cell study
Anna Maria Santoro1, Irene Monaco1,2, Francesco Attanasio1
1Istituto di Biostrutture e Bioimmagini - CNR Sede di Catania, Via P. Gaifami, 9- 95126 Catania, Italy.
Abstract:
Due to their altered metabolism cancer cells are more sensitive to proteasome inhibition or changes of copper levels than normal cells. Thus, the development of copper complexes endowed with proteasome inhibition features has emerged as a promising anticancer strategy. However, limited information is available about the exact mechanism by which copper inhibits proteasome. Here we show that Cu(II) ions simultaneously inhibit the three peptidase activities of isolated 20S proteasomes with potencies (IC50) in the micromolar range. Cu(II) ions, in cell-free conditions, neither catalyze red-ox reactions nor disrupt the assembly of the 20S proteasome but, rather, promote conformational changes associated to impaired channel gating. Notably, HeLa cells grown in a Cu(II)-supplemented medium exhibit decreased proteasome activity. This effect, however, was attenuated in the presence of an antioxidant. Our results suggest that if, on one hand, Cu(II)-inhibited 20S activities may be associated to conformational changes that favor the closed state of the core particle, on the other hand the complex effect induced by Cu(II) ions in cancer cells is the result of several concurring events including ROS-mediated proteasome flooding, and disassembly of the 26S proteasome into its 20S and 19S components.
Insights
Copper (II) ions inhibit proteasome activity in cancer cells by altering its structure and function. This proteasome inhibition, alongside ROS generation, presents a potential anticancer strategy.
Area of Science:
- Biochemistry
- Cell Biology
- Cancer Research
Background:
- Cancer cells exhibit altered metabolism, increasing sensitivity to proteasome inhibition and copper levels.
- Copper complexes with proteasome inhibition capabilities are a promising anticancer strategy.
- The precise mechanism of copper-mediated proteasome inhibition remains largely unelucidated.
Purpose of the Study:
- To investigate the mechanism by which copper (II) ions inhibit proteasome activity.
- To explore the effects of copper (II) on isolated 20S proteasomes and in cancer cells.
Main Methods:
- Inhibition assays using isolated 20S proteasomes.
- Analysis of copper (II) effects on proteasome conformation and assembly.
- Assessment of proteasome activity in HeLa cells cultured in copper (II)-supplemented media.
- Evaluation of antioxidant effects on copper (II)-induced cellular responses.
Main Results:
- Copper (II) ions inhibit all three peptidase activities of isolated 20S proteasomes (IC50 in micromolar range).
- Copper (II) does not induce redox reactions or disrupt 20S proteasome assembly but causes conformational changes affecting channel gating.
- Proteasome activity decreased in HeLa cells with copper (II) supplementation, an effect partially mitigated by antioxidants.
- Copper (II) induces ROS-mediated proteasome flooding and 26S proteasome disassembly in cancer cells.
Conclusions:
- Copper (II) inhibition of 20S proteasome activity involves conformational changes favoring a closed state.
- The anticancer effect of copper (II) in cancer cells results from multiple events, including ROS generation and proteasome disassembly.
- Copper (II) ions represent a potential therapeutic agent targeting proteasome function in cancer.
More Related Videos
14:44Structure and Coordination Determination of Peptide-metal Complexes Using 1D and 2D 1H NMR
Published on: December 16, 2013
11:04Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides
Published on: September 7, 2019
Related Concept Videos
The Proteasome Structure
The proteasome is an...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...